CDE Detailed Report
Disease: system
Subdomain Name: Imaging Diagnostics
CRF: files
Displaying 51 - 67 of 67
Subdomain Name: Imaging Diagnostics
CRF: files
Displaying 51 - 67 of 67
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C59044 | Imaging camera type other text | ImgCameraTypOTH | The free-text field related to 'Imaging camera type', specifying other text. Type of imaging camera used | The free-text field related to 'Imaging camera type', specifying other text. Type of imaging camera used | Other, specify | Alphanumeric |
No instructions available. |
No references available. | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:13:22.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C59055 | Imaging quantitative outcome vesicular monoamine transporter 2 radioligand type | ImgQuanOutVMAT2RadiolgndTyp | Type of vesicular monoamine transporter 2 (VMAT2) radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | Type of vesicular monoamine transporter 2 (VMAT2) radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | VMAT2 | AV133;DTBZ | AV133;DTBZ | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 1.00 | 2022-07-22 11:31:51.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C18698 | Imaging F-dopa binding ratio type other text | ImgFdopaBindRatTypOTH | The free-text field related to 'Imaging F-dopa binding ratio type' specifying other text. Type of F-dopa binding ratio with respect to the rest of the brain | The free-text field related to 'Imaging F-dopa binding ratio type' specifying other text. Type of F-dopa binding ratio with respect to the rest of the brain | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 2.00 | 2022-07-22 16:20:47.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08254 | Imaging visual analysis location performed type | ImgVisAnlysisLocPerfTyp | Type of location where visual analysis of the imaging data are performed | Type of location where visual analysis of the imaging data are performed | Where visual analysis was performed | Central;Other, specify;Local - Site | Central;Other, specify;Local - Site | Alphanumeric |
Choose one |
No references available | Adult | Supplemental-Highly Recommended | 3.10 | 2022-07-22 15:18:03.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||
| C18720 | Imaging visual analysis location performed type other text | ImgVisAnlysisLocPerfTypOTH | The free-text field related to 'Imaging visual analysis location performed type' specifying other text. Location where visual analysis of the imaging data are performed | The free-text field related to 'Imaging visual analysis location performed type' specifying other text. Location where visual analysis of the imaging data are performed | Other, specify | Alphanumeric |
Choose one |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-22 15:20:37.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08267 | Imaging outcome variable name | ImgOutcomeVarName | Name of the primary imaging outcome variable | Unit of measure used to specify the length of time medication(s) were withheld from the subject pre-treatment for the imaging scan | Imaging Outcome | Volume of interest;Voxel based;Other, specify | Volume of interest;Voxel based;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59045 | Imaging pre-scan procedure type carbidopa specify text | ImgPrescnProcdrTypCarbSpcfyTxt | The free-text field related to 'Imaging pre-scan procedure type', specifying Carbidopa details. Type(s) of pre-scan procedures administered to the participant/subject | The free-text field related to 'Imaging pre-scan procedure type', specifying Carbidopa details. Type(s) of pre-scan procedures administered to the participant/subject | Carbidopa, specify | Alphanumeric |
No instructions available. |
No references available. | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:15:18.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C59056 | Imaging quantitative outcome tyrosine hydroxylase radioligand type | ImgQuanOutTyrHydRadiolgndTyp | Type of tyrosine hydroxylase radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | Type of tyrosine hydroxylase radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | Tyrosine Hydroxylase | Fluoro-metatyrosine (FMT) | Fluoro-metatyrosine (FMT) | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 1.00 | 2022-07-22 11:37:33.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C01541 | Weight measurement | WgtMeasr | Measurement of participant's weight | Measurement of participant's weight | Current Body Weight | Numeric Values |
Record the weight of the participant/subject in kilograms (kg). To be collected at the visit, not self-reported. |
No references available | Adult | Supplemental-Highly Recommended | 3.10 | 2024-02-29 15:49:21.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
0 | 500 | kilogram | 2179689 | ||||||
| C18699 | Imaging isotope type other text | ImgIsotopeTypOTH | The free-text field related to 'Imaging isotope type' specifying other text. Type of radioactive isotope used for the imaging scan | The free-text field related to 'Imaging isotope type' specifying other text. Type of radioactive isotope used for the imaging scan | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-21 15:39:03.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08255 | Imaging visual analysis blinded indicator | ImgVisAnlysisBlindInd | Indicator of whether the visual analysis was performed blinded to clinical data | Indicator of whether the visual analysis was performed blinded to clinical data | Was the visual analysis performed blinded to clinical data? | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-25 08:54:08.2 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C18721 | Imaging visual analysis status other text | ImgVisAnlysisStatOTH | The free-text field related to 'Imaging visual analysis status' specifying other text. Status of findings from subjective review of image data | The free-text field related to 'Imaging visual analysis status' specifying other text. Status of findings from subjective review of image data | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-22 15:16:46.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08268 | Imaging volume of interest placement method type | ImgVOIPlacementMthdTyp | Type of method used for volume of interest (VOI) placement for the imaging data analysis | Type of method used for volume of interest (VOI) placement for the imaging data analysis | Method for VOI placement | Automated;Subjective Placement;Other, specify | Automated;Subjective Placement;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59046 | Imaging observe method status | ImgObserveMethdStat | Status related to the method of observation of participant/subject during scan | Status related to the method of observation of participant/subject during scan | Status of participant during scan | Directly observed;Movements recorded | Directly observed;Movements recorded | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:24:43.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||
| C59057 | Imaging amyloid centiloid anatomic site | ImgAmyloidCentiloidAnatSite | Anatomic site(s) for which quantitative estimations of amyloid plaque obtained by imaging were recorded using, or were scaled to, the Centiloid scale. | Anatomic site(s) for which quantitative estimations of amyloid plaque obtained by imaging were recorded using, or were scaled to, the Centiloid scale. | Amyloid Imaging Centiloids | Neocortex;Posterior cingual/precuneus;Frontal;Parietal;Lateral;Temporal;Mesiotemporal;Anterior cingulate;Striatum;Cerebellar gray;Whole cerebellum;Other, specify | Neocortex;Posterior cingual/precuneus;Frontal;Parietal;Lateral;Temporal;Mesiotemporal;Anterior cingulate;Striatum;Cerebellar gray;Whole cerebellum;Other, specify | Alphanumeric |
No instructions available |
Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4. doi: 10.1016/j.jalz.2014.07.003. Epub 2014 Oct 28. PMID: 25443857; PMCID: PMC4300247. | Adult | Supplemental | 1.00 | 2022-07-22 11:40:19.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||
| C02014 | Medication prior or concomitant name | MedctnPriorConcomName | Name of the prior/concomitant agent or drug administered | Name of the prior/concomitant agent or drug administere | Parkinson's Disease (PD) Medication | Alphanumeric |
Only answer if 'Yes' is answered for 'PD medications' |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-08-28 16:08:00.453 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
3162728 | ||||||||
| C18700 | Imaging matrix size value other text | ImgMatrixSizeValOTH | The free-text field related to 'Imaging matrix size value', specifying other text. Value representing the imaging matrix size in millimeters | The free-text field related to 'Imaging matrix size value', specifying other text. Value representing the imaging matrix size in millimeters | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-01 16:00:38.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 50 |
Free-Form Entry |
